FR284M - Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée. - Google Patents

Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.

Info

Publication number
FR284M
FR284M FR836743A FR836743A FR284M FR 284 M FR284 M FR 284M FR 836743 A FR836743 A FR 836743A FR 836743 A FR836743 A FR 836743A FR 284 M FR284 M FR 284M
Authority
FR
France
Prior art keywords
alpha
pregnadiene
amenorrhea
dione
dihydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836743A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR821678A external-priority patent/FR1430856A/fr
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FR836743A priority Critical patent/FR284M/fr
Application granted granted Critical
Publication of FR284M publication Critical patent/FR284M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR836743A 1959-03-18 1960-08-25 Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée. Active FR284M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836743A FR284M (fr) 1959-03-18 1960-08-25 Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US800103A US3038914A (en) 1959-03-18 1959-03-18 17-esters of 6-substituted-11-oxygenatedprogesterones
FR821678A FR1430856A (fr) 1960-03-17 1960-03-17 Procédé de fabrication d'esters de stéroïdes plus particulièrement de 17-estersde 17alpha-hydroxy-prégnane non saturé-3, 20-diones
FR836743A FR284M (fr) 1959-03-18 1960-08-25 Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.

Publications (1)

Publication Number Publication Date
FR284M true FR284M (fr) 1961-03-13

Family

ID=25177490

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836743A Active FR284M (fr) 1959-03-18 1960-08-25 Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.

Country Status (4)

Country Link
US (1) US3038914A (de)
CH (1) CH398578A (de)
FR (1) FR284M (de)
NL (1) NL6408818A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125590A (en) * 1964-03-17 Certificate of correction
US8796248B2 (en) * 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2837464A (en) * 1955-01-11 1958-06-03 Schering Corp Process for production of dienes by corynebacteria
US2875200A (en) * 1954-12-17 1959-02-24 Upjohn Co 9alpha-halo-11beta, 21-dihydroxy-4, 17(20)-pregnadiene-3-one compounds and process of preparing thereof
US2867637A (en) * 1957-05-17 1959-01-06 Upjohn Co 6alpha methyl, 9alpha f, 17alpha oh 1, 4 pregnadiene compounds
US2867638A (en) * 1957-05-17 1959-01-06 Upjohn Co 6-methyl-9alpha fluoro-11 oxygenated pregnenes
US2838536A (en) * 1957-11-29 1958-06-10 Upjohn Co 6-fluoro 9 alpha-halo-delta4-pregnenes and process for preparing same
US2838538A (en) * 1957-11-29 1958-06-10 Upjohn Co 6-fluoro steroids and process for preparing same
US2838496A (en) * 1957-11-29 1958-06-10 Upjohn Co 6-fluoro steroids and process for preparing same
US2892851A (en) * 1958-05-19 1959-06-30 Searle & Co 11-oxygenated derivatives of 9-fluoro-17-acyloxyprogesterones

Also Published As

Publication number Publication date
CH398578A (de) 1966-03-15
NL6408818A (de) 1965-02-25
US3038914A (en) 1962-06-12

Similar Documents

Publication Publication Date Title
FR1916M (fr) Médicament a base de 16.α-méthyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
FR284M (fr) Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.
CH423771A (fr) Procédé de préparation de la 6,17a-diméthyl- 4,6-prégnadiène-3,20-dione
FR2354M (fr) Composition a base de stéroide et d'acide 2-méthyl-3-indolyl-aliphatique pour le traitement des inflammations.
FR1996M (fr) Stéroides de la série de l'oestrane.
CH369756A (fr) Procédé pour la préparation de l'allopregnane-20-hydroxy-3-one et de l'allopregnane-3,20-dione
CH453349A (fr) Procédé de préparation d'hormones progestationnelles
CA536948A (en) 17.alpha.,21-DIHYDROXY-4-PREGNENE-3,11,20-TRIONE
FR1039M (fr) Médicament a base de ribonucléase pour le traitement du psoriasis et autres dermatoses.
FR1143M (fr) Médicament a base de dérivé pyimidique, notamment pour le traitement de l'hypercholestérolémie et de l'hyper-uricémie.
CA545558A (en) 4,17-dihydroxypregnane-3,11,20-trione
CA639507A (en) 11,17-dihydroxy progesterone
AU277389B2 (en) 21-glucuronides ofthe pregnane series andthat preparation
AU243668B2 (en) PROCESS FOR THE PREPARATION OF 17 a - ACYLOXY - 6a - METHYL - 16 - METHYLENE - PREGN - 4 - ENE - 3,20 - DIONES
CA536944A (en) 21-ACYLOXY-17.alpha.-HYDROXYPREGNANE-3,11,20-TRIONE AND PROCESS THEREFOR
CA560164A (en) Pregnane-3,7,20-trione
CA528614A (en) 3.beta.,11.alpha.-DIHYDROXY-5-PREGNENE-7,20-DIONE
AU228604B2 (en) 16, 20-diketo-17-hydroxy steroids ofthe pregnane series
CA551089A (en) 11-keto progesterone 3, 20-diketals
CA638839A (en) 9.beta.,11.beta.-OXIDO STEROID OF THE ANDROSTANE OR PREGNANE SERIES
CA617602A (en) Steroid 4,6-dienes
CA594678A (en) 3,11-diketo steroids of the pregnane series
AU264937B2 (en) 160:17a-METHYLPREGN-4-ENE-3:20-DIONE
FR2580M (fr) Médicament a base de guanylhydrazones de stéroides pour le traitement des insuffisances cardiaques.
CA616810A (en) 3.alpha.-ACYLOXY-16.alpha.-ALKYL-17.alpha.,21-DIHALO-PREGNANE-11,20-DIONE AND PROCESS FOR PREPARING THE SAME